Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jeannie Daniel"'
Autor:
Takaaki Tokito, Oleksii Kolesnik, Jens Sørensen, Mehmet Artac, Martín Lázaro Quintela, Jong-Seok Lee, Maen Hussein, Miklos Pless, Luis Paz-Ares, Lance Leopold, Jeannie Daniel, Mihaela Munteanu, Ayman Samkari, Lu Xu, Charles Butts
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Pembrolizumab is a first-line therapy for certain patients with advanced/metastatic non-small cell lung cancer (NSCLC). Combining pembrolizumab with other immunotherapies may enhance tumor cell killing and clinical outcomes. Epaca
Externí odkaz:
https://doaj.org/article/778d9a0bf7f040a3adf76b4a236aef6f
Autor:
Michael Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C. Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-12 (2024)
Abstract Background The combination of the checkpoint inhibitor (CPI) pembrolizumab and platinum-based chemotherapy is effective frontline therapy for advanced non-small cell lung cancer (NSCLC) lacking targetable mutations. Indoleamine 2,3- dioxygen
Externí odkaz:
https://doaj.org/article/f859d06395444ff68173b8d586898c31
Autor:
Rebecca Kristeleit, Howard Burris, Kristen Spencer, Sarina Piha-Paul, Hans Prenen, Tara Mitchell, David Pinato, Solmaz Sahebjam, Donna Graham, Nuria Kotecki, Eric Van Cutsem, Brant Delafontaine, Thomas Karasic, Jeannie Daniel, Kevin O’Hayer, Ryan Geschwindt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/7ed5aa6600e64e098a5e3fe1502b2f72
Autor:
Hans Prenen, Thierry Lesimple, Marie Robert, Brant Delafontaine, Jean-Pascal Machiels, Tarek Meniawy, Eric Van Cutsem, Nuria Kotecki, Sarina Piha-Paul, Michael Schweizer, Shirish Gadgeel, Jeannie Daniel, Louis Viviers, Jason Howe, Antoine Italiano
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
David Pinato, Ruth Plummer, Martin Gutierrez, Jeffrey Yachnin, Aglaia Schiza, Martin Hojgaard, Knut Smeland, William Edenfield, Hans Prenen, Lars Ny, Alan Anthoney, Nuria Kotecki, Stefan Symeonides, Louis Viviers, Jeannie Daniel, Jennifer Pulini, Udai Banerji
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Christophe Le Tourneau, Sarina Piha-Paul, Hans Prenen, Brant Delafontaine, David Pinato, Armando Santoro, Rebecca Kristeleit, Kristen Spencer, Tara Gangadhar, Howard Burris, Nuria Kotecki, Bristi Basu, Donna Graham, Anna Maria Di Giacomo, Solmaz Sahebjam, Massimo Di Nicola, Carlos Gomez-Roca, Pascale Tomasini, Paolo Ascierto, Giuseppe Curigliano, Thomas Karasic, Ryan Geschwindt, Jeannie Daniel, Eric Van Cutsem
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Lindsay Rein, Karel Calero, Ronak Shah, Charles Ojielo, Kristin M. Hudock, Saba Lodhi, Farid Sadaka, Shashi Bellam, Christopher Palma, David N. Hager, Jeannie Daniel, Richard Schaub, Kevin O’Hayer, Nicole M. Theodoropoulos
Publikováno v:
Critical care medicine. 50(12)
Evaluate the safety and efficacy of the Janus kinase (JAK)1/JAK2 inhibitor ruxolitinib in COVID-19-associated acute respiratory distress syndrome requiring mechanical ventilation.Phase 3 randomized, double-blind, placebo-controlled trial Ruxolitinib
Autor:
Sarah K Tasian, Deborah S Hunter, I-Ming L Chen, Richard C Harvey, Andrew J. Carroll, Elizabeth Wagner, Shalini C Reshmi, Michael J Borowitz, Brent L. Wood, Jeannie Daniel, Meenakshi Devidas, Elizabeth A. Raetz, Stephen P. Hunger, Albert Assad, Mignon L. Loh
Publikováno v:
Blood. 140:6117-6118
Autor:
Brant Delafontaine, Eric Van Cutsem, Kristen Spencer, Howard A. Burris, Kevin O’Hayer, Ryan Geschwindt, Solmaz Sahebjam, Nuria Kotecki, Jeannie Daniel, Rebecca Kristeleit, Donna Graham, Sarina Anne Piha-Paul, Hans Prenen, David J. Pinato, Thomas B. Karasic, Tara C. Mitchell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundINCB086550 is an orally administered small molecule that binds PD-L1 and inhibits PD-1/PD-L1 interaction. Translational data demonstrating markers of immune activation in patients following INCB086550 were previously reported.1 Preliminary
Autor:
David J. Terris, Katrina Chaung, Amanda Y. Behr, William S. Duke, Jennifer L. Waller, Sun Jung Oh, Jeannie Daniel
Publikováno v:
Otolaryngology–Head and Neck Surgery. 157:409-415
Objectives To define characteristics that influence patient perceptions of thyroidectomy scar cosmesis. Study Design Prospective cohort study. Setting Tertiary endocrine surgery practice in an academic medical center. Subjects and Methods Institution